Search Results - "Stevens‐Kroef, Marian J."

Clonal evolution in myelodysplastic syndromes by da Silva-Coelho, Pedro, Kroeze, Leonie I., Yoshida, Kenichi, Koorenhof-Scheele, Theresia N., Knops, Ruth, van de Locht, Louis T., de Graaf, Aniek O., Massop, Marion, Sandmann, Sarah, Dugas, Martin, Stevens-Kroef, Marian J., Cermak, Jaroslav, Shiraishi, Yuichi, Chiba, Kenichi, Tanaka, Hiroko, Miyano, Satoru, de Witte, Theo, Blijlevens, Nicole M. A., Muus, Petra, Huls, Gerwin, van der Reijden, Bert A., Ogawa, Seishi, Jansen, Joop H.

“…Cancer development is a dynamic process during which the successive accumulation of mutations results in cells with increasingly malignant characteristics…”
Get full text

HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study by Halilovic, Altuna, Verweij, Dagmar I., Simons, Annet, Stevens-Kroef, Marian J. P. L., Vermeulen, Susan, Elsink, Janet, Tops, Bastiaan B. J., Otte-Höller, Irene, van der Laak, Jeroen A. W. M., van de Water, Carlijn, Boelens, Oliver B. A., Schlooz-Vries, Margrethe S., Dijkstra, Jeroen R., Nagtegaal, Iris D., Tol, Jolien, van Cleef, Patricia H. J., Span, Paul N., Bult, Peter

“…Breast cancer treatment depends on human epidermal growth factor receptor-2 (HER2) status, which is often determined using dual probe fluorescence in situ…”
Get full text

Genomic array as compared to karyotyping in myelodysplastic syndromes in a prospective clinical trial by Stevens‐Kroef, Marian J., Olde Weghuis, Daniel, ElIdrissi‐Zaynoun, Najat, van der Reijden, Bert, Cremers, Eline M. P., Alhan, Canan, Westers, Theresia M., Visser‐Wisselaar, Heleen A., Chitu, Dana A., Cunha, Sonia M., Vellenga, Edo, Klein, Saskia K., Wijermans, Pierre, de Greef, Georgine E., Schaafsma, M. Ron, Muus, Petra, Ossenkoppele, Gert J., van de Loosdrecht, Arjan A., Jansen, Joop H.

“…Karyotyping is considered as the gold standard in the genetic subclassification of myelodysplastic syndrome (MDS). Oligo/SNP‐based genomic array profiling is a…”
Get full text

Next-generation cytogenetics: Comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping by Neveling, Kornelia, Mantere, Tuomo, Vermeulen, Susan, Oorsprong, Michiel, van Beek, Ronald, Kater-Baats, Ellen, Pauper, Marc, van der Zande, Guillaume, Smeets, Dominique, Weghuis, Daniel Olde, Stevens-Kroef, Marian J.P.L., Hoischen, Alexander

“…Somatic structural variants (SVs) are important drivers of cancer development and progression. In a diagnostic set-up, especially for hematological…”
Get full text

Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials by Ramadan, Safaa M., Suciu, Stefan, Stevens-Kroef, Marian J. P. L., Willemze, Roelof, Amadori, Sergio, de Witte, Theo, Löwenberg, Bob, Muus, Petra, Labar, Boris, Meert, Liv, de Schaetzen, Gaetan, Meloni, Giovanna, Leone, Giuseppe, Vignetti, Marco, Marie, Jean-Pierre, Lübbert, Michael, Baron, Frédéric

“…We report the outcomes of secondary acute myeloid leukemia (s-AML) patients included in one of 13 European Organisation for Research and Treatment of Cancer…”
Get full text

Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes by Cremers, Eline M P, Westers, Theresia M, Alhan, Canan, Cali, Claudia, Visser-Wisselaar, Heleen A, Chitu, Dana A, van der Velden, Vincent H J, Te Marvelde, Jeroen G, Klein, Saskia K, Muus, Petra, Vellenga, Edo, de Greef, Georgina E, Legdeur, Marie-Cecile C J C, Wijermans, Pierre W, Stevens-Kroef, Marian J P L, Silva-Coelho, Pedro da, Jansen, Joop H, Ossenkoppele, Gert J, van de Loosdrecht, Arjan A

“…Flow cytometric analysis is a recommended tool in the diagnosis of myelodysplastic syndromes. Current flow cytometric approaches evaluate the (im)mature…”
Get full text

Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone? by Jansen, Maurice P. H. M., Hopman, Anton H. N., Bot, Fredrik J., Haesevoets, Annick, Stevens-Kroef, Marian J. P. L., Arends, Jan Willem, Jox, Andrea, Wolf, Jürgen, Ramaekers, Frans C. S., Schouten, Harry C.

“…A recent study observed that numerical chromosome abnormalities in Hodgkin's disease (HD) are detected not only in morphologically abnormal…”
Get full text

Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling by Stevens-Kroef, Marian Jpl, van den Berg, Eva, Olde Weghuis, Daniel, Geurts van Kessel, Ad, Pfundt, Rolph, Linssen-Wiersma, Matty, Benjamins, Marloes, Dijkhuizen, Trijnie, Groenen, Patricia Jta, Simons, Annet

“…Characteristic genomic abnormalities in patients with B cell chronic lymphocytic leukemia (CLL) have been shown to provide important prognostic information…”
Get full text

Microarray-based genomic profiling and in situ hybridization on fibrotic bone marrow biopsies for the identification of numerical chromosomal abnormalities in myelodysplastic syndrome by Stevens-Kroef, Marian Jpl, Hebeda, Konnie M, Verwiel, Eugène T, Kamping, Eveline J, van Cleef, Patricia H, Kuiper, Roland P, Groenen, Patricia Jta

“…Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematological malignancies. In MDS patients with a fibrotic bone marrow the aspiration of…”
Get full text

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma by Zweegman, Sonja, van der Holt, Bronno, Mellqvist, Ulf-Henrik, Salomo, Morten, Bos, Gerard M.J., Levin, Mark-David, Visser-Wisselaar, Heleen, Hansson, Markus, van der Velden, Annette W.G., Deenik, Wendy, Gruber, Astrid, Coenen, Juleon L.L.M., Plesner, Torben, Klein, Saskia K., Tanis, Bea C., Szatkowski, Damian L., Brouwer, Rolf E., Westerman, Matthijs, Leys, M.(Rineke) B.L., Sinnige, Harm A.M., Haukås, Einar, van der Hem, Klaas G., Durian, Marc F., Mattijssen, E.(Vera)J.M., van de Donk, Niels W.C.J., Stevens-Kroef, Marian J.P.L., Sonneveld, Pieter, Waage, Anders

“…The combination of melphalan, prednisone, and thalidomide (MPT) is considered standard therapy for newly diagnosed patients with multiple myeloma who are…”
Get full text